Outsourcing STREAM
-
Building LEO Pharma's U.S. Presence with Brian Hilberdink
8/23/2023
In many respects, bringing an established foreign biopharma company to the U.S. market is not unlike starting one up from scratch. In other respects, it's even harder. The job's not for the faint of heart, which might be why the Danish company LEO Pharma tapped veteran biopharma leader Brian Hilberdink to lead its U.S. operations.
-
Protecting Biopharma Manufacturing Supply Chains
2/5/2026
In this final segment from the Bioprocess Online Live event, “Protecting Bioprocessing Operations and Supply Chains In A Turbulent Economy,” panelists Adam Golin, Jon Lindbloom, and James Sapirstein share their advice and best practices for sourcing suppliers and staying agile during periods of change in the industry.
-
Commercial Readiness with Orca Bio's Dan Kirby
9/14/2023
Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is to play in drug sales and marketing.
-
Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility
10/7/2022
Bionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future.
-
MilliporeSigma Capacity Update October 2025: ADC
7/28/2025
MilliporeSigma and Simtra's streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill/finish of drug substance.
-
The Journey To Safety Through Viral Clearance
12/1/2022
Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines. Learn how to free your teams and trust your project.
-
Microbiology Testing Systems Maintenance & Repair Services Plans
10/8/2024
Watch to learn about microbiology testing systems maintenance and repair services plans from a company with proven expertise.
-
Increasing The Reach Of Cell And Gene Therapies
4/29/2021
The cell and gene therapy industry is rapidly evolving from the perspective of “can we commercialize this class of therapeutics?” to “how do we reach patients who need these therapies?”. However, the promise of these biologics can only be realized if the industry approaches manufacturing parity with monoclonal antibodies. A mixture of innovation and brute-force streamlining is needed to create viable cell and gene therapy templates. In this video, we discuss how upstream process optimization is ripe for innovative approaches.
-
How MilliporeSigma Promotes Quality And Risk Reduction
10/20/2021
Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.
-
Explore The M Lab Collaboration Center In Burlington MA
9/19/2022
Our global network of scientific experts, innovative technologies, and non-GMP facilities, empower drug developers of all sizes to achieve manufacturing excellence and innovation through collaborative exploration and learning. Explore 1 of our 8 global facilities today.